Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from diabetes

Why isn’t Ozempic on Australia’s Pharmaceutical Benefits Scheme for weight loss? And should it be?

The drug is subsidised for treatment of type 2 diabetes but experts say it could help reduce other health problems associated with severe obesity

The Guardian - AU

Dr. Ergin's Holistic Diabetes Care: How SugarMD Is Empowering Women To Take Control

SugarMD offers a lifeline of hope for women seeking a holistic approach. This transformative care is now reaching women worldwide, including those in Australia, where access to innovative diabetes solutions is increasingly vital.

Medical Daily

Diabetic MP’s bid to ensure her condition is not included as cause for assisted death

Sarah Bool is calling for a list of conditions that should and should not be included in the controversial bill, due to concerns about its vagueness

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Semaglutide: a "wonder drug" with risks

New research is finding semaglutide, a diabetes and obesity drug, has a lot to teach about how the body works

Salon

In Texas’ Rio Grande Valley, a push for residents to lose weight and curb diabetes

In Brownsville, the city and local hospital have helped residents lose more than 23,000 pounds since 2008.

The Texas Tribune

“They’re Not Dead Until They’re Warm”: 30 Medical Facts That Should Come With A Warning Label

The world is full of curiosities. The post “They’re Not Dead Until They’re Warm”: 30 Medical Facts That Should Come With A Warning Label first appeared on Bored Panda.

Bored Panda

Several years ago, a little-known drug named Ozempic – previously used only to treat diabetes – emerged as a promising new drug for weight management.

The Conversation

Read news from The Economist, FT, and more,
with one subscription

Ultrasound Weight Loss: GE HealthCare and Novo Nordisk’s Play

GLP-1 drugs have been all the rage for weight loss, but GE Healthcare and Novo Nordisk are working on a non-invasive approach to controlling metabolic functions

MarketBeat

The fibre phenomenon: 30 easy ways to get your fill of this life-changing nutrient

It reduces the risk of heart disease, stroke, type 2 diabetes and colon cancer – while boosting the health of our gut microbiome and brain. Yet we all eat far too little fibre. Here is the no-fuss guide to getting your 30g a day

The Guardian - UK

I clock up to 20,000 steps a night: my life with restless legs syndrome

I spent years desperate for help and exhausted from lack of sleep. But the condition is badly misunderstood – even by doctors

The Guardian - US

Five ways to save your legs – by a vascular surgery specialist

Gangrene, or a rapidly spreading foot abscess. Sound like diseases of the past? Well, sadly not.

The Conversation

Got Prediabetes? Nutritionist Recommends Simple Hacks To Reverse It

Prediabetes could be the beginning of all your chronic woes. But what if you could reverse the condition without medications or complicated treatments?

Medical Daily

People on Ozempic may have fewer heart attacks, strokes and addictions – but more nausea, vomiting and stomach pain

Ozempic and Wegovy are increasingly available in Australia and worldwide to treat type 2 diabetes and obesity.

The Conversation

Weight-loss jabs linked to reduced risk of 42 conditions including dementia

Psychotic disorders also among conditions found less likely when people with diabetes took medications found in jabs

The Guardian - UK

Get all your
news in one place.

100’s of premium titles.
One news app.

LiveScience

Ozempic-style drugs tied to more than 60 health benefits and risks in biggest study-of-its-kind

A large new study has shed light on the wider health impacts of taking Ozempic-style drugs.

Fortune

Huge Ozempic and GLP-1 drug study finds they may lower risk of 42 health conditions, including heart attacks and Alzheimer’s disease

The study included nearly 2 million patients, making it the largest ever conducted on this group of glucagon-like peptide-1 receptor agonists.

Kiplinger

Medicare Price Negotiations To Continue Under the Trump Administration

The Centers for Medicare & Medicaid Services plans to negotiate the prices for 15 new drugs, although it says its seeking "greater transparency" in price talks.

Woman & Home

This free 'midlife MOT' can help catch heart disease and diabetes - why aren't we taking it up?

The NHS Health Check is a free service for anyone between 40 and 75 in the UK and it's been found to catch heart disease and dementia early

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

‘It’s alarming’: How Ozempic is being misused and worsening eating disorders

IN FOCUS: Olivia Petter talks to experts who say that people with eating disorders are especially vulnerable to the allure of ‘quick fix’ slimming with diabetes drug semaglutide... and are not thinking about its side effects

Fortune

Why this cardiologist—an ardent RFK Jr. supporter—wants you to avoid foods with 5 or more ingredients

The British cardiologist is presumably referring to foods that are processed or ultra-processed, which have been linked to cancer, heart disease, and diabetes.

The Conversation

How we diagnose and define obesity is set to change – here’s why, and what it means for treatment

Obesity is linked to many common diseases, such as type 2 diabetes, heart disease, fatty liver disease and knee osteoarthritis.

inkl

Unlocking the Secrets of Human Metabolism: The Power of Gene Knockout Libraries

The human metabolic system is a marvel of biological engineering, involving thousands of genes that interact in intricate pathways to sustain life. Disruptions in these pathways often underlie chronic diseases, such as diabetes, obesity, and metabolic syndromes.

Barchart

This Biotech Penny Stock Is Up 120% This Year. Analysts Think It Can Still Triple From Here in 2025.

With positive results from a clinical trial targeting Type 1 diabetes, Wall Street is feeling hot on this little biotech stock.

The Guardian - AU

66 days to cut down sugar: ‘I find myself enjoying the sweetness of my lip balm’

With a family history of diabetes, Sharlotte Thou knows she has to reduce the amount of sucrose in her diet. Will nine weeks be enough to tame her sweet tooth?

Salon

Olive leaf extract could be beneficial

"If you have high blood pressure, diabetes or raised blood lipids you may see some benefit . . ."

1 … 13 14 15 16

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.